SAR - Profile Therapeutics

3i Group PLC 3 November 2000 FORM SAR 5 Date of disclosure..3.11.00..... DISCLOSURE UNDER NOTE 3 OF RULE 5 OF THE RULES GOVERNING SUBSTANTIAL ACQUISITIONS OF SHARES ('SARs') Date of sale......2.11.00............................................... Sale of...........PROFILE THERAPEUTICS PLC......................(name of company) (1) Class of voting shares Number of shares/rights If rights over shares (eg ordinary shares) over shares sold sold, as opposed to the shares themselves, specify nature of rights .....ORDS 2p........ ..1,500,00......shares ...N/A.......... ................rights (2) Resultant total holding Resultant total holding Total percentage of voting shares (and % of rights over shares of total voting shares (and % of total voting in issue) shares in issue) ..10,785,501...(21.94 %) ...N/A........( %) ...21.94%.....( %) (3) Party making disclosure.........3i GROUP PLC........................ (4) (a) Name of person selling shares or rights over shares .3i GROUP PLC. and, if different, beneficial owner............................... (b) Names of any other persons acting by agreement or understanding (see SAR 5):3i SMALLER QUOTED COMPANIES TRUST PLC 3i BIOSCIENCE INVESTMENT TRUST PLC Signed, for and on behalf of the party named in (3) above................... (Also print name of signatory)....J DAVIES.................................. Telephone and extension number.............................................. For full details of the SARs disclosure requirements, see Rules 3 and 5 of the SARs. If in doubt, contact the Panel on Takeovers and Mergers, Tel. No: 020 7382 9026.

Companies

3i Group (III)
UK 100

Latest directors dealings